Heron Therapeutics Inc is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. HRTX has around 7.4M shares in the U.S. ETF market. The largest ETF holder of HRTX is the SPDR S&P Biotech ETF (XBI), with approximately 2.02M shares. Investors may also find of interest that the ETF with the largest allocation to HRTX stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 1.28%. On average, U.S. ETFs allocate 0.13% of HRTX to their portfolios.

Additionally, HRTX is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with HRTX as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 29.93%.